And it’s at least good to see that the ASX has demanded supplementary information from Starpharma on numerous occasions recently. 0000. 616553. 82%)And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Hope that SPL starts to deliver on its promises. Join the HotCopper ASX share market forum today for free. Within a post on another SPL thread, sarge17 said: "I wonder what polished horse turd of an announcement we will get from Starpharma in the final days leading up to the AGM. Expanding claims in UK- hmmm it would be a gamble by SPL to choose to put up that option rather than continue as is as MHRA may have same questions TGA has got ( whatever exactly they are) that don't seem to be resolved. Contacts. The SP must break out of the. 0¢. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. Created with Sketch. The main difference between shareholders and the board and their illustrious leader seems to be just in use of English language, small discrepancies like "well advanced" might me to you or I an agreement is pending, can be expected shortly, what it means to Jackie it would seem is she has undertaken a google search to see who might sell a product such as Viraleze in an particular country. Right size, can penetrate deep into tumour tissue, right architecture, hang around long enough to do the job, soluble so the. 0000. That's how markets work sometimes. 5. DYOR Why am am I still positive well let's go through my path to here in 2016/17/18 I was buying shares I bought one package of 100,000 for 66 cents and ended. This is just a lifestyle company at this point, management just keeping the company afloat with announcements that have no tangible impact on the share price while they collect their salaries. HotCopper is Australia's largest free and independent stock market trading forum for ASX share prices & stock market discussions. . So much coming up with Viraleze and DEP Starpharma team will be working very hard at the moment with so many balls in the air. Join the HotCopper ASX share market forum today for free. You got to wonder after huge volumes going through last 4 days and the SP reaching new lows. ASX - Day TradingSo the share price of SPL rose up to a high of $2. Latest Posts. 4. 8985. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Created with Sketch. As to finding the bottom, a milestone of sorts was reached today for SPHRY (the ADR on the US market equivalent to 10 SPL shares). The borders are now open Look forward to a positive outcome with new partnership agreements permeating from our team networking at ASCO. ASX - By Stock. The last time was December 2018. ASX - Day TradingThe short position has been negligible in Starpharma since we go booted from the ASX300 and the shorts were able to cover a large portion of their position at rock bottom share prices in the re-balance. 0¢. 5¢. Last updated 15. HotCopper has news, discussion, prices and market data on SOUTHERN CROSS PAYMENTS LTD. The latest Hotcopper Holdings [HOT] news, articles, data and analysis from The Australian Financial Review About this app. Below are 3 charts showing the predictions for Starpharma's Price by End 2019. Market . Join the HotCopper ASX share market forum today for free. . 19/09/23. 37pm 10/11/2023 ? HotCopper has news, discussion, prices and market data on WHISPIR LIMITED. My portfolio has risen 95% since I sold SPL with conviction. This of course is on the back of long-serving lap dog and CFO/Secretary Nigel Baade resigning around the same time that the ASX asked Starpharma questions regarding continuous disclosure obligations and also whether a SPL announcement was tantamount to ramping. Altech Batteries (ASX:ATC) has confirmed its Silumina Anodes project can be eight times larger than previously thought. , Inc. Twenty years later it’s 84. All IMO this highlights the problems with agreements where there is seemingly no min order quantity and obligation to advertise and promote the product. Talk with one of our capital. ASX - Day TradingCurrent SPL CEO setting a pretty high bar here, especially in light of the less than sparkling track record. ASX - Short Term Trading. Forums. It must be great to ride the ASX executive remuneration gravy train like CEO Fairley has done for 18 years with Starpharma, and Chairman Rob Thomas has done for the majority of his long career. The only double standard I see is that if any employee in the real world repeatedly told their boss that a project would definitely be delivered, every year since 2018 and the project has still not been delivered in early 2023 then they would be ceremoniously SACKED. Created with Sketch. Melbourne, Australia; 16 March 2021: Starpharma (ASX: SPL, OTCQX: SPHRY) today announced that its second radiopharmaceutical candidate, DEP® HER2-lutetium, achieved potent and durable anticancer activity, with complete tumour regression, outperforming Herceptin® (trastuzumab) labelled with lutetium, in a human breast cancer model (BT474). Join the HotCopper ASX share market forum today for free. And somebody must be buying all the shares that are being sold. Created with Sketch. SPL need to show and reassure them that AZD0466 was cancelled not because of the dendrimer technology. Hey, "smart", I concur with your message. ASX - By Stock. Virtual investor presentation Tomorrow night Starpharma will be Participating in a virtual investorpresentation on the OTC website for those that are. Share lol @col69 the phrase "in parallel we are continuing discussions with potential commercial partners" is now etched into SPL's manual for any asx announcements or releases to the public. Thanks for all your hard work and many successes during the year. Meanwhile SPL seems to get into more schoolyard fights and then disagreements with Authority than company I have watched. 0 Created with. Its a boring market today and I had time to revisit SPL, where I am a long, long time weary holder. Starpharma (SPL) Shares in the nano-biotechnology group bucked the falls in the wider market on Monday after it announced a deal with a division of US pharmaceutical giant Ely Lilly to extend the application of its technologies in the animal health area. Hey, "smart", I concur with your message. Starpharma have so far been quite disappointing in the way it has commercialised products The Vivagel condom A dismal failure so far It had been approved. ASX - General. Offers an alternative as reasons for delays, been at the mercy of regulators playing catch-up somewhat. 0¢ Sentiment: Hold Disclosure: Held Share Hi Folks Time to revisit the SPL Weekly chart. ASX - General. However, I think that maybe SPL is occasionally worth a swing trade gamble. Last edited by sarge17 : 19/09/20 SPL Price at posting: $1. This extract caught my eye"The AstraZeneca programs involves $US124 million of milestones, about half of which are “relatively near”. ASX - Day TradingHi guys, I have held SPL shares for over 9 years and I will continue to hold. SUBMISSION STEPS. Hey, "smart", I concur with your message. 74. No China virus, no Flu, no colds. 22/9/2000 CSL $11. Is this a case of short memories? The best one can say is her surprise is disingenuous. 1. The thread is titled so that it can be found and general enough so as to. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Charts. Join the HotCopper ASX share market forum today for free. Canadian Dollar. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . any other information the entity wishes to notify to ASX about the cessation?The Performance Rights issued under an employee incentive scheme lapsed during the course of the quarter ended 30June 2023 include 519,053 Rights held by KMP, Nigel Baade, and 310,760 Rights held by non-KMPs. And that is my opinion too but about SPL. I was hoping for. 8985. Join the HotCopper ASX share market. SPL. 0¢ STARPHARMA HOLDINGS LIMITED - Corporate Spotlight . I have today made my own enquiries with AstraZeneca directly on 1-877-240-9479 and they (Camellia) have confirmed that this trial is not yet recruiting and she also confirmed that the day recruitment starts the status on the website will be updated. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. ASX - Day TradingGood to see another Aussie biotech who has been in communication with the FDA over the last 2 years since receiving a CRL have had their BLA resubmission accepted by the FDA. 10 Year Chart looks like a rollercoaster:But the spike in volume over the past month suggests:a) We're near a huge breakoutORb) We're near a huge. 25. Join the HotCopper ASX share market forum today for free. caBC OnLine Partnership Office E161, 4000 Seymour Place PO Box 9412, Stn Prov Govt Victoria, BC V8W 9V1Share. Join the HotCopper ASX share market forum today for free. A sad state of affairs IMO. . Commodities. Advertise on HotCopper. Last edited by antibotter : 13/11/23. He doesn't "hold" but 99% of his posts are on SPL, including a remarkable 350 in the last two months alone. Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. com Investors: Chas Cook — 336-436-5076 Investor@Labcorp. As to finding the bottom, a milestone of sorts was reached today for SPHRY (the ADR on the US market equivalent to 10 SPL shares). To make matters worse he has AZD0466 on hold through no fault of the dendrimer technology, which appears to be highly successful in dealing with the drugs toxicity. BCSPL – VI Wave. 2. 5. 0¢. 70. Latest Posts. distraction achieved. 28pm 13/11/2023 ? TMG (ASX) Chart. 6 MILLION HY LOSS FROM CONTINUING OPERATIONS. Along with SPL's seemingly better ADC compared to AZ's Enhertu, perhaps Pascal Soriot is wondering if he jumped into bed with the the wrong partner in Daiichi-Sankyo. Created with Sketch. Build your trading strategy and connect with. My theory is we had a large accumulator that was content buying. . 3¢. SPL Ann: Application for quotation of securities - SPL SPL starpharma holdings limited Ann: Application for quotation of securities - SPL ASX News 851. NSX - By Stock. m. Created with Sketch. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Last updated 10. I’ve seen numerous cases across Hotcopper where a shareholder with a large investment will say whatever it takes, over a sustained period of years, even though it may be highly optimistic, knowingly false or misleading, in an attempt to protect their own investment, even at the expense of other less experienced Hotcopper members and investors. LEADING THE BATTERY METALS REVOLUTION. municipal. SPL Price at posting: 71. Some links within this article worth a scan too. ACCELERATE RESOURCES LIMITED. 22%) 3,361,416 was the lowest point of total short sales for some years as of 15/06/23 (0. Merck has tightened its ties to Starpharma as it continues to build out its antibody-drug conjugate (ADC) capabilities, signing a second agreement that will enable. Do they actually work day in day out? Do research everyday? If so why after 20 years we are still at phase 1/2. ASX - Day Trading. 0. “Who in at SPL made these commitments on timelines?” ~ @Joelsmith2452 CEO Jackie Fairley first told shareholders that the current Phase 2 DEP-Docetaxel trial would be complete by the end of CY2018. It’s incredibly important to keep us informed. 3. ASX - By Stock. 56am 20/11/2023 ? HotCopper has news, discussion, prices and market data on MAGNIS ENERGY TECHNOLOGIES LTD. Created with Sketch. The latest Hotcopper Holdings [HOT] news, articles, data and analysis from The Australian Financial ReviewAbout this app. Share It's confusing isn't it So what we have in pre-clinical trials Dep Docetaxel has been used in combination with Gemcitabine Dep Cabazitaxel has been used in combination with GemcitabineReading the TGA decision to fine Starpharma re Viraleze in 2021, and the requirement that SPL apply for approval of Viraleze as Medicine not Medical Device which has been the approval category in many other jurisdictions, I understand from questions I asked at the November 2022 AGM that SPL paid the fine and were concerned that there. yet if one considers that the amount of millions of shares via option they. . 1dB. Market . New Zealand Dollar. Share Yes, this is pre-clinical data, HOWEVER, on this occasion this positive data (of adding Starpharma’s conjugate to IO drugs) directly supports commercial negotiations for the soon to be released top-line results for DEP-Irinotecan, in my opinion. 57% 13. Market Cap $55. comImagine what SPL's newflow and updates would look like without Viraleze. HotCopper has news, discussion, prices and market data on SPLITIT PAYMENTS LTD. In summary, my observations about SPL are: Marketing - persistent. SPL Price at posting: $1. . Starpharma was 96 cents in April 2002. Join the HotCopper ASX share. 0¢ Sentiment: Hold Disclosure: Held LikesSPL 7013 is already approved for use in the body (via a mucous membrane) and there would seem to be no issue as regards safety. ASX - Day TradingLet's face it SPL is a very small investment for most of the institutions, they work on the basis of having a portfolio of these "penny dreadfuls" and expect some to come good but most to fail. I recall reading your postings (largely optimistic, I think) about SPL when I first stumbled onto this site years ago. Can you imagine. This is what faces SPL's DEP product business, and so far they seem incapable of fighting through the maze to get recognised and accepted. . $1. Forums. ASX - Short. m. Some days I wondered if I'd see 91c again, but when the Vivagel phase 3 announcement came out I loaded up big time. ZEUS RESOURCES LIMITED. The recent announcement about Viraleze nasal spray going into production in Jan 2021, trying to hit the Euro markets in q1-q2 2021, caused a stir in the SP. 15667. I think with SPL we are up to series 10 episode 100!!!! and I do laugh a lot mostly at posters naiviety On your part pretty poor form comparing such a classic comedy with such a tragic live comedy watched on the market everyday !!Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. I wonder if LLoyds are taking the pain on 50% off or if SPL rebating just to get volume and name in market ? LLoyds depending on agreemnet would usually just return stock IMO. . 8¢. See All Discussions. When it goes to 62 cents, and it will as it's 1 cent away, it will be a 282-week low, or 5 years 8 months since it's been at that level, that's a lot of holders if not all on them in the red. There appears to be a different behavioural feel about. HotCopper has over 250,000 registered members, and more than 200,000 unique visitors every month and a huge 21 million monthly page impressions. , page-2. Timeline. 375% 0. . Join the HotCopper ASX share market forum today for free. Disowned him really. 70. I averaged down over the next year and the lowest point I bought was at 57c. . ASX - Day Trading. Volume. The recent announcement about Viraleze nasal. 75. Deliver ZERO dividends, a NEGATIVE capital return and depressed share price to shareholders over a 17 year period. Model # 407730 Store SKU # 1000846365. ca/pst. 48. ASX - Day TradingTime to top up again for me What about youBetween Oct 2017 and Mar 2018 it seemed like we held pretty consistently above $1. Market . 0. Join the. granted mgt haven’t covered themselves in glory as yet but the selldown has been nothing short of astonishing. When a board member uses rheir own hard earned cash and buys $350,000 worth of shares. Starpharma is listed on the Australian stock exchange (ASX:SPL). ASX - Day TradingIn my opinion, most rational people would have to concede/agree that Starpharma’s three SPL7013 commercialised products (Fleurstat, condoms and Viraleze) have been commercial flops so far. . The 407730 is a sound level meter that measures from 40 to 130dB with an accuracy of 2dB. SPL Price at posting: 16. 0¢. 5¢. I'd think that SPL will be covering all the bases required for a crack at 505b2, but with the necessary data to pivot to a phase 3 trial if. I've been a SPL shareholder since Nov 2015 when I bought a small parcel at 91c. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. Canadian Dollar. . It would be nice to have SPL make an announcement to the market to clear up the uncertainty around the many market sensitive announcements made that seem to have just faded into the background with no update as to whether they are progressing or if they have ceased. Is the board simply resting on their collective (pre spl) laurels?Just in case you missed it HEALTHCARE Starpharma (SPL) Strong results from first in man Phase 1 DEP Docetaxel trial validate SPL’s DEP platform Safety. As to finding the bottom, a milestone of sorts was reached today for SPHRY (the ADR on the US market equivalent to 10 SPL shares). - 12:30 p. It seems long-suffering retail. I find it alarming the number of column inches in the resolution explanatory notes, extolling their experiences prior to spl, when not one of them has any achievements in the advancement of spl listed. Even Pfizer won’t comment on him. 73. Commodities. Just to refresh people's memory I thought this summed by the exact situation with the TGA and Starpharm STARPHARMA’S COVID-KILLER NEEDS ACTION NOT. 16,161,259. 26. It is, to me, incredibly frustrating that SPL releases a good report with great promise and income mentions yet the market response is LIMP with a rise of. ASX - By Stock. . It knows of Viraleze - so its rationale for letting Viraleze meander through regulatory processes with no due haste or intervention is mystifying. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. ASX - By Stock. Overview. We have oft heard the CEO brag about the $1B+ value of the AZD0466 milestones and license revenues. Everyone holding SPL shares should now realise that unless they can have a deal signed on at least one of the Dep candidates within 3 to 6 months with a substantial upfront payment then a CR will definately be on the cards. 615, today the share price rose by 0. ASX - By Stock. Market . 375) mark and followed up with a roughly 23. m. SPL Price at posting: 14. Follow your favourite stocks, view charts, track gainers and losers and discuss topics including politics, commodities, cryptocurrency and managed funds. 52 (16th Feb) on the back of the hype that surrounded the launch of VIRALEZE in UK/EU/WORLD. Created with Sketch. “If humans respond in a similar way, the benefits of treatment. It totally unrealistic that Merck will enter the clinic in 4-5 months. Share Interesting and positive early pre-clinical results. . Antibotter despite you starting 23 separate Starpharma threads in 3 weeks you do not own this Hotcopper forum. . All the case studies have already been touted by SPL in various ASX announcements and the only trial that is declared finished by Starpharma and scheduled for readouts is DEP. Join the HotCopper ASX share market forum today for free. 409118. 6¢. This is a charting thread for those interested in the movements of the SPL SP. ASX - Day Trading. 06B ! Add to my watchlist. . As to finding the bottom, a milestone of sorts was reached today for SPHRY (the ADR on the US market equivalent to 10 SPL shares). Eight (8) contributors to the HC SPL thread made price predictions (thank. Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. ”For your information 55% of the company is held by institutions” ~ AB I. Share New future tech coming Antibody fragment-nanoparticle therapeutic eradicates cancerPosted YesterdayA multi-institutional team of researchers found novel cancer therapeutic, combining antibody fragments with molecularly engineered nanoparticles, permanently eradicating gastric cancer in treated mice. . 00%. $-0. Twelve month SPL daily chartSame old trend continues. The reason I loaded up in the year post the last agm was because we we falsely told that vivagel would would be launched in Q1. Ineffective deals and sloppy clinical trials and regulatory tactics might be able to be gloss over for years but over times it show in the bottom line. Last edited by sarge17: 28/11/22. Once they think they can get AZD0466 to market they will pounce if our share price is less tan $2. Latest Posts. My last 350 posts take me back over two years and cover about twenty different stocks. )” ~@antibotter Jan 2019 (Hotcopper post #37005569) After ASX announcement ‘Positive DEP phase 2 interim results in prostate cancer’:Peak of the UK Flu season looks to have passed . Its time SPL got down and dirty and prepare their WAR plan in anticipation of the trial being successful. 0012. 00% 14. 04KBIMO there’s money to be made trading SPL but I do not believe in holding, hoping, trusting and loving SPL at all. Click for more information. Follow your favourite stocks, view charts, track. Join Australia’s largest community of ASX investors and share market enthusiasts in our free and independent stock market forum. Market Cap $58. There were 17,468,532 shares dumped on Monday 18/10 and as per M & G notice today only 4,359,271 shares were from M & G on Monday. Volume. Forex. $0. SPL always has tantalising carrots to dangle before the eyes of investors. Created with Sketch. 0 Great. ” ~@sarge17 Last edited by sarge17 : 24/02/23 SPL Price at posting: 54. The results will be good but will they be good enough for SPL to be able to do the deals. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . 03% or subsequently a decrease in shorts of. but hey don't take my word for it, see for yourself in the official SPL ASX announcement dated 17th April 2023 You would think that somewhere SPL woudl have commented that TGA is awaiting data from UK trial. )” ~@antibotter Jan 2019 (Hotcopper post #37005569) After ASX announcement ‘Positive DEP phase 2 interim results in prostate cancer’: SPL are obliged to make announcements and unfortunately they have not included enough detail so shareholders are aware of timings and actual release in Indonesia nor real scale. Market Dep Cabazitaxel will be licenced out before initiation of Phase 2 clinical trial (in other words this year. SPL. I recall reading your postings (largely optimistic, I think) about SPL when I first stumbled onto this site years ago. 24am 31/10/2023 ? Share Prices & Charts for STARPHARMA HOLDINGS LIMITED. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . $0. Slow golf clap for Jackie Fairley. ASX - Day TradingLast day Spl remains in ASX300 Institutions and/or shorters buying TIME LINE At auction today there were 20 million shares wanted to buy and 11 millions shares wanted to sell Notice after close of auction there were still 10 million shares wanted to buy and 450k to sellThe deal, which has an initial duration of 12 months, has the same terms as the previous agreement. Created with Sketch. 8985. Not going to go over all the posts that are detailing what the spl7013 antiviral nasal spray may mean to the world others have done a great job. 52pm 13/10/2023 ? HotCopper has news, discussion, prices and market data on STARPHARMA HOLDINGS LIMITED. Join the HotCopper ASX share market forum today for free. Quarterly Activities Report & Appendix 4CLooking further into the AGM notice, Resolution 3 is a massive slap in the face to share holders!!!Basically the company is proposing to dish out a bonus. I can't guess where or what or when, perhaps there is an informed opinion out there in HC SPL land but we have a very tight market and some. If only we had the viraleze. Everyone holding SPL shares should now realise that unless they can have a deal signed on at least one of the Dep candidates within 3 to 6 months with a substantial. Created with Sketch. . Advertise on HotCopper. Some links within this article worth a scan too. . I think SPL are very worried on what a potential class action could implicate. 5 years Starpharma has not publicly released any information to the ASX about progress of the partnership. Dec 14 (Reuters) - Starpharma Holdings Ltd (SPL) : VIRALEZE NASAL SPRAY REGISTERED IN INDONESIA PROGRESSING DISCUSSIONS WITH POTENTIAL DISTRIBUTION. . . The goal of the partnership. 5¢. International Markets. 971M ! Add to my watchlist. ASX - By Stock. Target our investor community with our suite of Hotcopper. Canadian Dollar. 16,364,160. 0¢. 0%. 13. I recall reading your postings (largely optimistic, I think) about SPL when I first stumbled onto this site years ago. ASX - By Stock. ASX - General. Latest Posts. In SPL's case there is clearly another. You would think that somewhere SPL woudl have commented that TGA is awaiting data from UK trial. 50 peak) that they hadn’t missed the boat and that SPL was soon going to $3. Latest Posts. Eight (8) contributors to the HC SPL thread made price predictions (thank. Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. The matter has been adjourned to. Application for quotation of securities - SPL. Sorry a Faulty Towers and BMC tragic and possibly a SPL one as well . Created with Sketch. Melbourne, Australia; 16 March 2021: Starpharma (ASX: SPL, OTCQX: SPHRY) today announced that its second radiopharmaceutical candidate, DEP® HER2-lutetium, achieved potent and durable anticancer activity, with complete tumour regression, outperforming Herceptin® (trastuzumab) labelled with lutetium, in a human breast cancer. . However, just a word of caution before the usual pumping starts by the usual suspects. IMO maybe you positive posters should just take a breather for a little while and wait until the tide turns and this company shows some signs of life?Sept 28 (Reuters) - Starpharma Holdings Ltd (SPL) : REQUESTS FOR A TRADING HALT PENDING AN ANNOUNCEMENT TO MARKET REGARDING A PROPOSED EQUITY CAPITAL. Latest Posts. We love cruising, but this multi billion dollar industry has effectively been shut down. Charts. 0. and the Government Medical Research Fund which provided $1mil to SPL to aid in developing Viraleze. 0¢. 45K. So on the one hand you state SPL isn't a nasal spray company. Market . Add SPL (ASX) to my watchlist (20min delay). 88. Market . IMO they haven't . . Last updated 15. Views. 4¢. Created with Sketch. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . 3. . Created with Sketch. So SPL have written responses to shareholders saying Viraleze is avaliable under existing exclusive deal with LLoyds but for some unknown reason SPL have developed a " dedicated VIRALEZE™ product UK webstore" and "other online channels" conveniently at a time when LLoyds seem to have destocked stores and webstore no. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . . “It wouldn't surprise me if Starpharma have and are talking with big pharma in a joint collaboration to further develop SPL7013 for other. They are the future as also mentioned regularly by Eric Topol. Then you have the obvious issues with distribution with Lloydsand possiblly really cheap deal with Vietnam let alone teh mysterious India ,.